We are live on ! Find out more
MSL

Mackay Shields LLC Portfolio holdings

AUM $2.73B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+3.7%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$14.7B
AUM Growth
+$876M
Cap. Flow
-$1.87B
Cap. Flow %
-12.75%
Top 10 Hldgs %
18.45%
Holding
1,576
New
196
Increased
607
Reduced
424
Closed
176

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 10.44%
3 Consumer Discretionary 8.69%
4 Healthcare 8.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNG icon
701
RingCentral
RNG
$4.05B
$2.71M 0.02%
23,581
+12,450
+112% +$1.44M
UFS
702
DELISTED
DOMTAR CORPORATION (New)
UFS
$2.7M 0.02%
60,711
-96,026
-61% -$4.39M
PCTY icon
703
Paylocity
PCTY
$6.71B
$2.7M 0.02%
28,786
+9,186
+47% +$872K
RST
704
DELISTED
ROSETTA STONE INC
RST
$2.7M 0.02%
+117,911
New +$2.84M
DOC icon
705
Healthpeak Properties
DOC
$15.4B
$2.69M 0.02%
84,237
-280,028
-77% -$8.71M
FDS icon
706
Factset
FDS
$9.05B
$2.68M 0.02%
+9,347
New +$2.59M
BDC icon
707
Belden
BDC
$4B
$2.68M 0.02%
44,934
+35,934
+399% +$2.06M
KYNB
708
Kyntra Bio
KYNB
$28.5M
$2.67M 0.02%
2,368
+1,434
+154% +$1.57M
PLAB icon
709
Photronics
PLAB
$1.79B
$2.67M 0.02%
325,837
+282,237
+647% +$2.51M
EXR icon
710
Extra Space Storage
EXR
$31.2B
$2.67M 0.02%
25,167
-13,805
-35% -$1.45M
PARA
711
DELISTED
Paramount Global Class B
PARA
$2.67M 0.02%
53,484
-1,425
-3% -$70.5K
RMD icon
712
ResMed
RMD
$28.3B
$2.65M 0.02%
21,746
-8,212
-27% -$910K
BLMN icon
713
Bloomin' Brands
BLMN
$680M
$2.63M 0.02%
138,990
+69,399
+100% +$1.36M
FOLD
714
DELISTED
Amicus Therapeutics
FOLD
$2.63M 0.02%
210,506
+135,601
+181% +$1.72M
ONCE
715
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.6M 0.02%
25,409
+16,387
+182% +$1.77M
KEYS icon
716
Keysight
KEYS
$54.5B
$2.6M 0.02%
28,955
+321
+1% +$27.3K
ANSS
717
DELISTED
Ansys
ANSS
$2.6M 0.02%
12,689
-1,486
-10% -$283K
BAND
718
Bandwidth Inc
BAND
$1.91B
$2.6M 0.02%
+34,600
New +$2.52M
WRK
719
DELISTED
WestRock Company
WRK
$2.59M 0.02%
71,068
+29,897
+73% +$1.1M
NMY
720
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
$2.59M 0.02%
200,000
TNL icon
721
Travel + Leisure Co
TNL
$4.54B
$2.58M 0.02%
58,816
-8,762
-13% -$374K
K
722
DELISTED
Kellanova
K
$2.58M 0.02%
51,297
+11,927
+30% +$633K
COLL icon
723
Collegium Pharmaceutical
COLL
$1.14B
$2.57M 0.02%
195,636
+153,036
+359% +$2.05M
SVC
724
Service Properties Trust
SVC
$1.1B
$2.57M 0.02%
20,531
-15,998
-44% -$2.05M
CSOD
725
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$2.57M 0.02%
44,319
+31,919
+257% +$1.73M

Similar funds

Mackay Shields LLC's Q2 2019 Portfolio in Review

As of Q2 2019, Mackay Shields LLC held 1,576 positions worth $14.7B, up 6.4% from $13.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Mackay Shields LLC withdrew a net $1.87B in Q2 2019, closing 176 positions and reducing 424 holdings. Its most notable exit was Extended Stay America, Inc. Paired Share Unit, an estimated $7.92M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Mackay Shields LLC opened a new position in Invesco National AMT-Free Municipal Bond ETF worth $48.9M.

  • Mackay Shields LLC's largest Q2 2019 buy was Invesco National AMT-Free Municipal Bond ETF: 1,870,000 shares worth $48.9M.
  • Mackay Shields LLC added most to Coterra Energy in Q2 2019, an estimated $20.5M increase.
  • Mackay Shields LLC's biggest Q2 2019 reduction was Apple, cutting an estimated $43.7M.
  • Mackay Shields LLC fully exited Extended Stay America, Inc. Paired Share Unit in Q2 2019, selling an estimated $7.92M.
  • Mackay Shields LLC's ten largest holdings make up 18% of its $14.7B portfolio in Q2 2019.
  • Mackay Shields LLC opened 196 new positions and closed 176 in Q2 2019.
  • Mackay Shields LLC's portfolio value rose 6.4% quarter-over-quarter to $14.7B.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.